NPY strongly suppresses hippocampal sharp waves while only weakly affecting gamma oscillations, revealing selective modulation of memory circuits.
Selective suppressionNPY strongly inhibits sharp wave-ripples but minimally affects gamma oscillations in hippocampus
What the researchers found
NPY differentially suppresses hippocampal network patterns — strongly inhibiting sharp waves while minimally affecting gamma oscillations.
Why it matters
This explains how NPY can reduce fear memory and prevent seizures without broadly disrupting brain function — it selectively targets specific network patterns.
The numbers in context
Effects measured in C57BL/6 male mouse brain slices; Y2 receptor mediated; CA1 > CA3 effects.
How the study worked
In vitro brain slice electrophysiology in C57BL/6 mice using pharmacological tools targeting specific NPY receptor subtypes.
Who was studied
C57BL/6 male mice (brain slice preparations)
What this study cannot tell us
In vitro brain slice model — network dynamics in intact brains may differ. Only male mice studied.
How to read the evidence
In vitro electrophysiology with pharmacological dissection — high mechanistic value but limited clinical translatability.
When this study was published
Published in 2025, advancing understanding of NPY's network-level effects.
The bigger picture
Understanding NPY's selective network effects could lead to targeted therapies for PTSD, epilepsy, and anxiety that preserve normal cognitive function.
Questions still open
- Could NPY-based drugs selectively suppress traumatic memory consolidation?
- Do these network effects explain NPY's anticonvulsive properties?
Common questions
What is Neuropeptide Y?
How does NPY affect memory?
Read the original research
Differential suppression of hippocampal network oscillations by neuropeptide Y.
Neuropharmacology, 266, 110281
Citation
Pollali, Evangelia; Draguhn, Andreas. (2025). Differential suppression of hippocampal network oscillations by neuropeptide Y.. Neuropharmacology, 266, 110281. https://doi.org/10.1016/j.neuropharm.2024.110281